NEMATEL-P 439 MG/G ORAL PASTE FOR HORSES
Země: Irsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Charakteristika produktu
(SPC)
17-06-2024
Některé dokumenty pro tento produkt momentálně nejsou k dispozici, můžete poslat požadavek našemu zákaznickému servisu a my vás upozorníme, jakmile je dokážeme získat.
Poslat žádost.
Poslat žádost.
Aktivní složka:
PYRANTEL EMBONATE
Dostupné s:
Le Vet Beheer B.V.
ATC kód:
QP52AF02
INN (Mezinárodní Name):
PYRANTEL EMBONATE
Dávkování:
439 mg/g
Léková forma:
Oral Paste
Druh předpisu:
LM-Licensed Merchant
Terapeutické skupiny:
Equine - Food
Terapeutické oblasti:
Pyrantel
Terapeutické indikace:
Endoparasiticide
Stav Autorizace:
Authorised
Datum autorizace:
2012-05-04
Charakteristika produktu
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nematel-P 439 mg/g oral paste for horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral paste
Yellow, viscous, oily paste
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, ponies and foals (of over 8 weeks of age).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Infestations with adult stages of roundworm, particularly ascarids (_Parascaris equorum_), small strongyles
(_Cyathostomum spp., Triodontophorus spp_.) and large strongyles (_Strongylus edentatus, Strongylus equinus, Strongylus_
_vulgaris_), seatworm/pinworm (_Oxyuris equi_) and tapeworm (_Anoplocephala perfoliata_) in horses, ponies and foals.
The efficacy towards Anoplocaphala perfoliata is variable.
4.3 CONTRAINDICATIONS
Do not use in animals known to be hypersensitive to the active substance.
COMPOSITION PER GRAM
ACTIVE SUBSTANCE:
Pyrantel embonate (equivalent to 152.2 mg of pyrantel)
439 mg
EXCIPIENT(S):
Methyl parahydroxybenzoate (E218)
1
mg
Propyl parahydroxybenzoate (E216).
0.3
mg
For a full list of excipients, see section 6.1.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 16/06/2014_
_CRN 7017853_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment against tapeworms should only be undertaken when tapeworms have been diagnosed.
Resistance to pyrantel embonate has been reported in cyathostomins in horses. Therefore the use of this product should
be based on local (regional, farm) epidemiological information about susceptibility of cyathostomins and
recommendations on how to limit further selection for resistance to anthelmintics.
Care should be taken to avoid the following practices because they increase the risk of developm
Přečtěte si celý dokument
